إعلان
إعلان
ALGS
Aligos Therapeutics, Inc. Common Stock
10.21
USDبرعاية
+0.55
+5.75%
٠٨ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
9.99
-0.21
-2.11%
تقارير أرباح ALGS
النسبة الإيجابية المفاجئة
ALGS تفوق 11 من 21 آخر التقديرات.
52%
التقرير التالي
بيانات التقرير القادم
٠٩ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$816.00K
/-$1.60
التغير الضمني من Q3 25 (Revenue/ EPS)
+10.12%
/-47.37%
التغير الضمني من Q4 24 (Revenue/ EPS)
+29.73%
/-52.94%
Aligos Therapeutics, Inc. Common Stock earnings per share and revenue
On ٠٦ نوفمبر ٢٠٢٥, ALGS reported earnings of -3.04 USD per share (EPS) for Q3 25, missing the estimate of -1.93 USD, resulting in a -56.86% surprise. Revenue reached 741.00 ألف, compared to an expected 510.00 ألف, with a 45.29% difference. The market reacted with a -3.14% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 المحللين forecast an EPS of -1.60 USD, with revenue projected to reach 816.00 ألف USD, implying an نقصان of -47.37% EPS, and زيادة of 10.12% in Revenue from the last quarter.
الأسئلة الشائعة
What were Aligos Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Aligos Therapeutics, Inc. Common Stock reported EPS of -$3.04, missing estimates by -56.86%, and revenue of $741.00K, 45.29% above expectations.
How did the market react to Aligos Therapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -3.14%, changed from $7.33 before the earnings release to $7.10 the day after.
When is Aligos Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٠٩ مارس ٢٠٢٦.
What are the forecasts for Aligos Therapeutics, Inc. Common Stock's next earnings report?
Based on 6
المحللين, Aligos Therapeutics, Inc. Common Stock is expected to report EPS of -$1.60 and revenue of $816.00K for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان